AI in 2025: Transforming the B2B Sales Landscape

MELBOURNE,Australia,Dec. 17,2024-- As we move into 2025,the potential of AI is reshaping how sales teams operate,engage,and deliver value. Sales teams that fail to leverage AI risk being left behind

12-18

TCL Hosts Global Technology Innovation Conference, Showcasing Latest AI and Display Innovations

SHENZHEN,China,Dec. 17,2024-- On December 11,the 2024TCL Global Technology Innovation Conference (TIC) was held in Shenzhen. With the theme "The Future is Visible by AI",the conference focus

12-18

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

CUPERTINO,Calif.,Dec. 17,2024-- Microbio Co.,Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-smal

12-18

EO Charging Recognized by Frost & Sullivan with the Product Leadership Award for Enabling Energy Efficiency, Cost-effectiveness, and Grid Reliability in Fleet Charging and Energy Management

EO\'s smart charging hardware and intelligent charging and energy management software provide efficient and reliable charging,enable high uptime,and give fleet managers granular control over their EV

12-18

Candlelight Vigil and International Peace Assembly Held in Nanjing to Commemorate National Memorial Day

NANJING,China,Dec. 16,2024-- A news report fromXinhuanet North America: On December 13,the National Memorial Day for Victims of theNanjing Massacre,a solemn Candlelight Vigil and International Peace A

12-18

Discover the Wonders of China in Unparalleled Style with Train of Glamour's New 2025 Routes

Journey Beyond the Ordinary: The Train is The Destination SHANGHAI,Dec. 16,2024-- Embark on a journey where the voyage itself becomes a destination of grandeur—welcome to the Train of Glamour,China\'

12-18

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

– Both pivotal studies achievedprimary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p<0.0001)

12-18

Sir Alastair Cook joins GEDU as a Global Brand Ambassador

LONDON,Dec. 16,2024-- Global Education (GEDU) has been unveiled as the official Education Partner of the Professional Cricketers\' Association (PCA); with England cricketing legend Sir Alastair Cook a

12-18

Global Times: Macao Science-1 a successful example of 'one country, two systems' advantage

BEIJING,Dec. 17,2024--The successful launch of Macao Science-1 satellites,the first space science satellite program jointly developed by the Chinese mainland and Macao,owes much to the strong support

12-18

Divine Offerings: Shinon Washoku Senryū Brings Spiritual Japanese Cuisine to Osaka

Experience Washoku as a Sacred Connection Between Humanity,Nature and Tradition OSAKA,Japan,Dec. 17,2024--As Osaka prepares to host the highly anticipated Expo 2025,the city welcomes an extraordinary

12-18